|
1
|
Prasad P, Verma S, Surbhi, Ganguly NK,
Chaturvedi V and Mittal SA: Rheumatoid arthritis: Advances in
treatment strategies. Mol Cell Biochem. 478:69–88. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kan S, Duan M, Liu Y, Wang C and Xie J:
Role of mitochondria in physiology of chondrocytes and diseases of
osteoarthritis and rheumatoid arthritis. Cartilage. 13 (2
Suppl):1102S–1121S. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou S and Huang G: Some important
inhibitors and mechanisms of rheumatoid arthritis. Chem Biol Drug
Des. 99:930–943. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Minichiello E, Semerano L and Boissier MC:
Time trends in the incidence, prevalence, and severity of
rheumatoid arthritis: A systematic literature review. Joint Bone
Spine. 83:625–630. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akiyama M and Kaneko Y: Pathogenesis,
clinical features, and treatment strategy for rheumatoid
arthritis-associated interstitial lung disease. Autoimmun Rev.
21:1030562022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelly C, Emery P and Dieudé P: Current
issues in rheumatoid arthritis-associated interstitial lung
disease. Lancet Rheumatol. 3:e798–e807. 2021. View Article : Google Scholar
|
|
7
|
Conforti A, Di Cola I, Pavlych V, Ruscitti
P, Berardicurti O, Ursini F, Giacomelli R and Cipriani P: Beyond
the joints, the extra-articular manifestations in rheumatoid
arthritis. Autoimmun Rev. 20:1027352021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akira M, Sakatani M and Hara H:
Thin-section CT findings in rheumatoid arthritis-associated lung
disease: CT patterns and their courses. J Comput Assist Tomogr.
23:941–948. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koduri G, Norton S, Young A, Cox N, Davies
P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, et al:
Interstitial lung disease has a poor prognosis in rheumatoid
arthritis: Results from an inception cohort. Rheumatology (Oxford).
49:1483–1489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee HK, Kim DS, Yoo B, Seo JB, Rho JY,
Colby TV and Kitaichi M: Histopathologic pattern and clinical
features of rheumatoid arthritis-associated interstitial lung
disease. Chest. 127:2019–2027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zamora-Legoff JA, Krause ML, Crowson CS,
Ryu JH and Matteson EL: Progressive decline of lung function in
rheumatoid arthritis-associated interstitial lung disease.
Arthritis Rheumatol. 69:542–549. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vergnenègre A, Pugnere N, Antonini MT,
Arnaud M, Melloni B, Treves R and Bonnaud F: Airway obstruction and
rheumatoid arthritis. Eur Respir J. 10:1072–1078. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bilgici A, Ulusoy H, Kuru O, Celenk C,
Unsal M and Danacı M: Pulmonary involvement in rheumatoid
arthritis. Rheumatol Int. 25:429–435. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Natalini JG, Swigris JJ, Morisset J,
Elicker BM, Jones KD, Fischer A, Collard HR and Lee JS:
Understanding the determinants of health-related quality of life in
rheumatoid arthritis-associated interstitial lung disease. Respir
Med. 127:1–6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh N, Varghese J, England BR, Solomon
JJ, Michaud K, Mikuls TR, Healy HS, Kimpston EM and Schweizer ML:
Impact of the pattern of interstitial lung disease on mortality in
rheumatoid arthritis: A systematic literature review and
meta-analysis. Semin Arthritis Rheum. 49:358–365. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shaw M, Collins BF, Ho LA and Raghu G:
Rheumatoid arthritis-associated lung disease. Eur Respir Rev.
24:1–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aslam B, Basit M, Nisar MA, Khurshid M and
Rasool MH: Proteomics: Technologies and their applications. J
Chromatogr Sci. 55:182–196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yasuda T, Tahara K and Sawada T: Detection
of salivary citrullinated cytokeratin 13 in healthy individuals and
patients with rheumatoid arthritis by proteomics analysis. PLoS
One. 17:e02656872022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu S, Ji W, Lu J, Tang X, Guo Y, Ji M, Xu
T, Gu W, Kong D, Shen Q, et al: Discovery of potential serum
protein biomarkers in ankylosing spondylitis using tandem mass
tag-based quantitative proteomics. J Proteome Res. 19:864–872.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou G, Wei P, Lan J, He Q, Guo F, Guo Y,
Gu W, Xu T and Liu S: TMT-based quantitative proteomics analysis
and potential serum protein biomarkers for systemic lupus
erythematosus. Clin Chim Acta. 534:43–49. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu X, Jeong Y, Poli de Frías S, Easthausen
I, Hoffman K, Oromendia C, Taheri S, Esposito AJ, Quesada Arias L,
Ayaub EA, et al: Serum proteomic profiling of rheumatoid
arthritis-interstitial lung disease with a comparison to idiopathic
pulmonary fibrosis. Thorax. 77:1041–1044. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song LN, Kong XD, Wang HJ and Zhan LB:
Establishment of a rat adjuvant arthritis-interstitial lung disease
model. Biomed Res Int. 2016:29707832016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
National Institutes of Health (U.S.), .
Office for Protection from Research Risks: Public Health Service
policy on humane care and use of laboratory animals. Office for
Protection from Research Risks (OPRR). National Institutes of
Health; 1986, PubMed/NCBI
|
|
24
|
An ZP: BS: Lung function test in wistar
rats. Chin J Lab Anim Sci. 12:102–104. 2013.
|
|
25
|
Wei X, Zhou R, Chen Y, Ma G, Yang Y, Lu C,
Xu W and Hu W: Systemic pharmacological verification of Baixianfeng
decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating
rheumatoid arthritis. Bioorg Chem. 119:1055192022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goldner J: A modification of the masson
trichrome technique for routine laboratory purposes. Am J Pathol.
14:237–243. 1938.PubMed/NCBI
|
|
27
|
Szapiel SV, Elson NA, Fulmer JD,
Hunninghake GW and Crystal RG: Bleomycin-induced interstitial
pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis.
120:893–899. 1979.PubMed/NCBI
|
|
28
|
Wiśniewski JR, Zougman A, Nagaraj N and
Mann M: Universal sample preparation method for proteome analysis.
Nat Methods. 6:359–362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen C, Chen H, Zhang Y, Thomas HR, Frank
MH, He Y and Xia R: TBtools: An integrative toolkit developed for
interactive analyses of big biological data. Mol Plant.
13:1194–1202. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Figus FA, Piga M, Azzolin I, McConnell R
and Iagnocco A: Rheumatoid arthritis: Extra-articular
manifestations and comorbidities. Autoimmun Rev. 20:1027762021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schurgers E, Mertens F, Vanoirbeek JA, Put
S, Mitera T, De Langhe E, Billiau A, Hoet PH, Nemery B, Verbeken E
and Matthys P: Pulmonary inflammation in mice with collagen-induced
arthritis is conditioned by complete Freund's adjuvant and
regulated by endogenous IFN-γ. Eur J Immunol. 42:3223–3234. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lei W and Jian L: Changes of CD4(+)
CD25(+) regulatory T cells, FoxP3 in adjuvant arthritis rats with
damage of pulmonary function and effects of tripterygium glycosides
tablet. Int J Rheumatol. 2012:3484502012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lucas R, Czikora I, Sridhar S, Zemskov EA,
Oseghale A, Circo S, Cederbaum SD, Chakraborty T, Fulton DJ,
Caldwell RW and Romero MJ: Arginase 1: An unexpected mediator of
pulmonary capillary barrier dysfunction in models of acute lung
injury. Front Immunol. 4:2282013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JT, Li C, Weiss HL, Zhou Y, Liu C,
Wang Q and Evers BM: Regulation of ketogenic enzyme HMGCS2 by
Wnt/β-catenin/PPARγ pathway in intestinal cells. Cells. 8:11062019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su SG, Yang M, Zhang MF, Peng QZ, Li MY,
Liu LP and Bao SY: miR-107-mediated decrease of HMGCS2 indicates
poor outcomes and promotes cell migration in hepatocellular
carcinoma. Int J Biochem Cell Biol. 91:53–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Elorza A, Soro-Arnáiz I,
Meléndez-Rodríguez F, Rodríguez-Vaello V, Marsboom G, de Cárcer G,
Acosta-Iborra B, Albacete-Albacete L, Ordóñez A, Serrano-Oviedo L,
et al: HIF2α acts as an mTORC1 activator through the amino acid
carrier SLC7A5. Mol Cell. 48:681–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sokolov AM, Holmberg JC and Feliciano DM:
The amino acid transporter Slc7a5 regulates the mTOR pathway and is
required for granule cell development. Hum Mol Genet. 29:3003–3013.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nojima Y, Takeda Y, Maeda Y, Bamba T,
Fukusaki E, Itoh MN, Mizuguchi K and Kumanogoh A: Metabolomic
analysis of fibrotic mice combined with public RNA-Seq human lung
data reveal potential diagnostic biomarker candidates for lung
fibrosis. FEBS Open Bio. 10:2427–2436. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ehrnthaller C, Ignatius A, Gebhard F and
Huber-Lang M: New insights of an old defense system: Structure,
function, and clinical relevance of the complement system. Mol Med.
17:317–329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dunkelberger JR and Song WC: Complement
and its role in innate and adaptive immune responses. Cell Res.
20:34–50. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hanna J, Ah-Pine F, Boina C, Bedoui Y,
Gasque P and Septembre-Malaterre A: Deciphering the role of the
anaphylatoxin C3a: A key function in modulating the tumor
microenvironment. Cancers (Basel). 15:29862023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Monk PN, Scola AM, Madala P and Fairlie
DP: Function, structure and therapeutic potential of complement C5a
receptors. Br J Pharmacol. 152:429–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo Z, Fan X, Yao J, Tomlinson S, Yuan G
and He S: The role of complement in nonalcoholic fatty liver
disease. Front Immunol. 13:10174672022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Triggianese P, Conigliaro P, De Martino E,
Monosi B and Chimenti MS: Overview on the link between the
complement system and auto-immune articular and pulmonary disease.
Open Access Rheumatol. 15:65–79. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Luo R, Wang T, Zhuo S, Guo X and Ma D:
Excessive hydrogen sulfide causes lung and brain tissue damage by
promoting PARP1/Bax and C9 and inhibiting LAMB1. Apoptosis.
27:149–160. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pellicano C, Miglionico M, Romaggioli L,
Colalillo A, Vantaggio L, Napodano C, Callà C, Gulli F, Marino M,
Basile U and Rosato E: Increased Complement activation in systemic
sclerosis patients with skin and lung fibrosis. J Pers Med.
12:2842022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ogawa T, Shichino S, Ueha S, Ogawa S and
Matsushima K: Complement protein C1q activates lung fibroblasts and
exacerbates silica-induced pulmonary fibrosis in mice. Biochem
Biophys Res Commun. 603:88–93. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Duerr J, Leitz DHW, Szczygiel M, Dvornikov
D, Fraumann SG, Kreutz C, Zadora PK, Seyhan Agircan A, Konietzke P,
Engelmann TA, et al: Conditional deletion of Nedd4-2 in lung
epithelial cells causes progressive pulmonary fibrosis in adult
mice. Nat Commun. 11:20122020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Y, Lv X, Chen L and Liu Y: The role
and function of CLU in cancer biology and therapy. Clin Exp Med.
Sep 13–2022.(Epub ahead of print). View Article : Google Scholar
|
|
50
|
Ishikawa Y, Ishii T, Akasaka Y, Masuda T,
Strong JP, Zieske AW, Takei H, Malcom GT, Taniyama M, Choi-Miura NH
and Tomita M: Immunolocalization of apolipoproteins in aortic
atherosclerosis in American youths and young adults: Findings from
the PDAY study. Atherosclerosis. 158:215–225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hong JY, Kim MN, Kim EG, Lee JW, Kim HR,
Kim SY, Lee SM, Kim YH, Kim KW and Sohn MH: Clusterin deficiency
exacerbates hyperoxia-induced acute lung injury. Cells. 10:9442021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fox CR and Parks GD: Complement inhibitors
vitronectin and clusterin are recruited from human serum to the
surface of coronavirus OC43-infected lung cells through
antibody-dependent mechanisms. Viruses. 14:292021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang Q, Yue Y and Zheng R: Clusterin as a
serum biomarker candidate contributes to the lung fibroblasts
activation in chronic obstructive pulmonary disease. Chin Med J
(Engl). 135:1076–1086. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Blom AM, Kask L and Dahlbäck B:
Structural requirements for the complement regulatory activities of
C4BP. J Biol Chem. 276:27136–27144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ermert D and Blom AM: C4b-binding protein:
The good, the bad and the deadly. Novel functions of an old friend.
Immunol Lett. 169:82–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Khadzhieva M, Kuzovlev AN and Salnikova
LE: Pneumonia: Host susceptibility and shared genetics with
pulmonary function and other traits. Clin Exp Immunol. 198:367–380.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dasari P, Koleci N, Shopova IA, Wartenberg
D, Beyersdorf N, Dietrich S, Sahagún-Ruiz A, Figge MT, Skerka C,
Brakhage AA and Zipfel PF: Enolase from Aspergillus fumigatus is a
moonlighting protein that binds the human plasma complement
proteins factor H, FHL-1, C4BP, and plasminogen. Front Immunol.
10:25732019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kulkarni HS, Liszewski MK, Brody SL and
Atkinson JP: The complement system in the airway epithelium: An
overlooked host defense mechanism and therapeutic target? J Allergy
Clin Immunol. 141:1582–1586. e12018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kyung Lee M, Armstrong DA, Hazlett HF,
Dessaint JA, Mellinger DL, Aridgides DS, Christensen BC and Ashare
A: Exposure to extracellular vesicles from Pseudomonas aeruginosa
result in loss of DNA methylation at enhancer and DNase
hypersensitive site regions in lung macrophages. Epigenetics.
16:1187–1200. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Armstrong DA, Lee MK, Hazlett HF, Dessaint
JA, Mellinger DL, Aridgides DS, Hendricks GM, Abdalla MAK,
Christensen BC and Ashare A: Extracellular vesicles from
Pseudomonas aeruginosa suppress MHC-related molecules in human lung
macrophages. Immunohorizons. 4:508–519. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gaurav R, Mikuls TR, Thiele GM, Nelson AJ,
Niu M, Guda C, Eudy JD, Barry AE, Wyatt TA, Romberger DJ, et al:
High-throughput analysis of lung immune cells in a combined murine
model of agriculture dust-triggered airway inflammation with
rheumatoid arthritis. PLoS One. 16:e02407072021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ricklin D, Hajishengallis G, Yang K and
Lambris JD: Complement: A key system for immune surveillance and
homeostasis. Nat Immunol. 11:785–797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lener M, Vinci G, Duponchel C, Meo T and
Tosi M: Molecular cloning, gene structure and expression profile of
mouse C1 inhibitor. Eur J Biochem. 254:117–122. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chaudhary N, Jayaraman A, Reinhardt C,
Campbell JD and Bosmann M: A single-cell lung atlas of complement
genes identifies the mesothelium and epithelium as prominent
sources of extrahepatic complement proteins. Mucosal Immunol.
15:927–939. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Danobeitia JS, Ziemelis M, Ma X, Zitur LJ,
Zens T, Chlebeck PJ, Van Amersfoort ES and Fernandez LA: Complement
inhibition attenuates acute kidney injury after
ischemia-reperfusion and limits progression to renal fibrosis in
mice. PLoS One. 12:e01837012017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Curci C, Castellano G, Stasi A, Divella C,
Loverre A, Gigante M, Simone S, Cariello M, Montinaro V, Lucarelli
G, et al: Endothelial-to-mesenchymal transition and renal fibrosis
in ischaemia/reperfusion injury are mediated by complement
anaphylatoxins and Akt pathway. Nephrol Dial Transplant.
29:799–808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang Z, Nicholson SE, Cancio TS, Cancio LC
and Li Y: Complement as a vital nexus of the pathobiological
connectome for acute respiratory distress syndrome: An emerging
therapeutic target. Front Immunol. 14:11004612023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kotlyarov S and Kotlyarova A:
Anti-Inflammatory function of fatty acids and involvement of their
metabolites in the resolution of inflammation in chronic
obstructive pulmonary disease. Int J Mol Sci. 22:128032021.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kočar E, Režen T and Rozman D:
Cholesterol, lipoproteins, and COVID-19: Basic concepts and
clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids.
1866:1588492021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tanner JE and Alfieri C: The fatty acid
lipid metabolism nexus in COVID-19. Viruses. 13:902021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hu X, Ge X, Liang W, Shao Y, Jing J, Wang
C, Zeng R and Yao B: Effects of saturated palmitic acid and omega-3
polyunsaturated fatty acids on Sertoli cell apoptosis. Syst Biol
Reprod Med. 64:368–380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Chu SG, Villalba JA, Liang X, Xiong K,
Tsoyi K, Ith B, Ayaub EA, Tatituri RV, Byers DE, Hsu FF, et al:
Palmitic acid-rich high-fat diet exacerbates experimental pulmonary
fibrosis by modulating endoplasmic reticulum stress. Am J Respir
Cell Mol Biol. 61:737–746. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Jo Y, Sguigna PV and DeBose-Boyd RA:
Membrane-associated ubiquitin ligase complex containing gp78
mediates sterol-accelerated degradation of
3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem.
286:15022–15031. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Huang SSY, Toufiq M, Saraiva LR, Van
Panhuys N, Chaussabel D and Garand M: Transcriptome and literature
mining highlight the differential expression of ERLIN1 in immune
cells during sepsis. Biology (Basel). 10:7552021.PubMed/NCBI
|
|
75
|
Patrick MT, Stuart PE, Zhang H, Zhao Q,
Yin X, He K, Zhou XJ, Mehta NN, Voorhees JJ, Boehnke M, et al:
Causal relationship and shared genetic loci between psoriasis and
type 2 diabetes through trans-disease meta-analysis. J Invest
Dermatol. 141:1493–1502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ma APY, Yeung CLS, Tey SK, Mao X, Wong
SWK, Ng TH, Ko FCF, Kwong EML, Tang AHN, Ng IO, et al: Suppression
of ACADM-mediated fatty acid oxidation promotes hepatocellular
carcinoma via aberrant CAV1/SREBP1 signaling. Cancer Res.
81:3679–3692. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Dong Y, Lu H, Li Q, Qi X, Li Y, Zhang Z,
Chen J and Ren J: (5R)-5-hydroxytriptolide ameliorates liver lipid
accumulation by suppressing lipid synthesis and promoting lipid
oxidation in mice. Life Sci. 232:1166442019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Xu Y, Denning KL and Lu Y: PPARα agonist
WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance
peroxisomal lipid metabolism and ameliorate alcoholic fatty liver
in mice. Biochem Biophys Res Commun. 613:47–52. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kong A, Xu D, Hao T, Liu Q, Zhan R, Mai K
and Ai Q: Role of acyl-coenzyme A oxidase 1 (ACOX1) on
palmitate-induced inflammation and ROS production of macrophages in
large yellow croaker (Larimichthys crocea). Dev Comp Immunol.
136:1045012022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Vallée A, Lecarpentier Y, Guillevin R and
Vallée JN: Interactions between TGF-β1, canonical WNT/β-catenin
pathway and PPAR γ in radiation-induced fibrosis. Oncotarget.
8:90579–90604. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Milam JE, Keshamouni VG, Phan SH, Hu B,
Gangireddy SR, Hogaboam CM, Standiford TJ, Thannickal VJ and Reddy
RC: PPAR-gamma agonists inhibit profibrotic phenotypes in human
lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J
Physiol Lung Cell Mol Physiol. 294:L891–L901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Biniecka M, Canavan M, McGarry T, Gao W,
McCormick J, Cregan S, Gallagher L, Smith T, Phelan JJ, Ryan J, et
al: Dysregulated bioenergetics: A key regulator of joint
inflammation. Ann Rheum Dis. 75:2192–2200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ma C, Wei J, Zhan F, Wang R, Fu K, Wan X
and Li Z: Urinary hypoxia-inducible factor-1alpha levels are
associated with histologic chronicity changes and renal function in
patients with lupus nephritis. Yonsei Med J. 53:587–592. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Manresa MC and Taylor CT: Hypoxia
inducible factor (HIF) hydroxylases as regulators of intestinal
epithelial barrier function. Cell Mol Gastroenterol Hepatol.
3:303–315. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Fu X and Zhang F: Role of the HIF-1
signaling pathway in chronic obstructive pulmonary disease. Exp
Ther Med. 16:4553–4561. 2018.PubMed/NCBI
|
|
86
|
Yu H, Li Q, Kolosov VP, Perelman JM and
Zhou X: Regulation of cigarette smoke-mediated mucin expression by
hypoxia-inducible factor-1α via epidermal growth factor
receptor-mediated signaling pathways. J Appl Toxicol. 32:282–292.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Tzouvelekis A, Harokopos V, Paparountas T,
Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A,
Bouros D and Aidinis V: Comparative expression profiling in
pulmonary fibrosis suggests a role of hypoxia-inducible
factor-1alpha in disease pathogenesis. Am J Respir Crit Care Med.
176:1108–1119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Bryant AJ, Carrick RP, McConaha ME, Jones
BR, Shay SD, Moore CS, Blackwell TR, Gladson S, Penner NL, Burman
A, et al: Endothelial HIF signaling regulates pulmonary
fibrosis-associated pulmonary hypertension. Am J Physiol Lung Cell
Mol Physiol. 310:L249–L262. 2016. View Article : Google Scholar : PubMed/NCBI
|
